GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (MEX:LABB) » Definitions » PB Ratio

Genomma Lab InternacionalB de CV (MEX:LABB) PB Ratio : 2.46 (As of Dec. 16, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Genomma Lab InternacionalB de CV PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-16), Genomma Lab InternacionalB de CV's share price is MXN27.41. Genomma Lab InternacionalB de CV's Book Value per Share for the quarter that ended in Sep. 2024 was MXN11.15. Hence, Genomma Lab InternacionalB de CV's PB Ratio of today is 2.46.

The historical rank and industry rank for Genomma Lab InternacionalB de CV's PB Ratio or its related term are showing as below:

MEX:LABB' s PB Ratio Range Over the Past 10 Years
Min: 1.03   Med: 2.07   Max: 4.1
Current: 2.46

During the past 13 years, Genomma Lab InternacionalB de CV's highest PB Ratio was 4.10. The lowest was 1.03. And the median was 2.07.

MEX:LABB's PB Ratio is ranked worse than
57.6% of 941 companies
in the Drug Manufacturers industry
Industry Median: 2.06 vs MEX:LABB: 2.46

During the past 12 months, Genomma Lab InternacionalB de CV's average Book Value Per Share Growth Rate was -0.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 4.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 10.10% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 2.20% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Genomma Lab InternacionalB de CV was 91.90% per year. The lowest was -12.70% per year. And the median was 13.90% per year.

Back to Basics: PB Ratio


Genomma Lab InternacionalB de CV PB Ratio Historical Data

The historical data trend for Genomma Lab InternacionalB de CV's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomma Lab InternacionalB de CV PB Ratio Chart

Genomma Lab InternacionalB de CV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.61 2.17 2.14 1.60 1.42

Genomma Lab InternacionalB de CV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.20 1.42 1.52 1.54 2.03

Competitive Comparison of Genomma Lab InternacionalB de CV's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomma Lab InternacionalB de CV's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's PB Ratio distribution charts can be found below:

* The bar in red indicates where Genomma Lab InternacionalB de CV's PB Ratio falls into.



Genomma Lab InternacionalB de CV PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Genomma Lab InternacionalB de CV's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=27.41/11.152
=2.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Genomma Lab InternacionalB de CV  (MEX:LABB) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Genomma Lab InternacionalB de CV PB Ratio Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomma Lab InternacionalB de CV Business Description

Traded in Other Exchanges
Address
Avenida Antonio Dovali Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Genomma Lab InternacionalB de CV Headlines

No Headlines